
|Videos|November 5, 2021
Nonsteroidal Mineralcorticoid Receptor Antagonists in Managing Hyperkalemia
Dr. Cary Boyd-Shiwarski explains how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.
Advertisement
Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."
Boyd explained how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
World Lung Cancer Day: Pharmacists Are Essential Across Prevention, Screening, and Treatment
2
A Pharmacist's Guide to Probiotics for Preventing Traveler’s Diarrhea
3
July 2026 in Pain Management: 10 Developments That Advanced and Challenged Patient Care
4
Five Solid Tumor Advances That Defined July 2026
5





































































































